Sunshine Healthcare Lanka Limited (SHL), the healthcare of expanded conglomerate Sunshine Holdings PLC (CSE: SUN), announced approximately LKR 3,270 million equity investment from the International Finance Corporation (IFC), a member of the World Bank Group. This investment is a milestone that strengthens SHL’s vision to expand healthcare accessibility and boost innovation across Sri Lanka.
This investment marks a significant landmark in Sri Lanka's growth narrative as one of the notable foreign direct equity investments since the economic crisis, signaling the country's renewed stability and resilience. Private investments like this will be instrumental in driving Sri Lanka’s economic transformation, demonstrating its readiness as a nation for a broader economic recovery.
SHL aims to significantly expand its pharmaceutical manufacturing capability by doubling its capacity in respiratory products. SHL also aims to enhance diagnostic capabilities by investing in state-of-the-art medical devices, providing better access to cutting-edge healthcare technology with enhanced efficiency and productivity.
Following the successful completion of this transaction, IFC now holds a 14.73% equity stake in SHL. This strategic partnership will allow SHL to speed up the execution of key capital projects that aim to reshape healthcare delivery in the country, including significant expansions in manufacturing, and medical devices.
“We are proud to conclude this investment with IFC, underscoring our commitment to nation-building through local and responsible entrepreneurship. This partnership strengthens Sunshine’s role in enhancing healthcare accessibility and contributes to the country’s economic resilience at a critical time. With IFC’s support, we are significantly ramping up local pharmaceutical manufacturing and bolstering our healthcare infrastructure, ensuring all Sri Lankans have access to high-quality, locally produced pharmaceuticals and innovative healthcare solutions. This marks an important step in driving sustainable development and self-reliance in the nation’s healthcare sector”, said Group Chief Executive Officer Shyam Sathasivam.